BACK TO TOP
KSE100
181,259.67
-369.69
(-0.20%)
KSE100PR
55,267.99
-112.72
(-0.20%)
ALLSHR
109,929.76
-12.56
(-0.01%)
KSE30
54,098.61
-180.86
(-0.33%)
KMI30
255,607.53
-762.23
(-0.30%)
BKTI
51,158.12
-368.09
(-0.71%)
OGTI
36,542.82
-231.76
(-0.63%)
KMIALLSHR
70,648.66
21.76
(0.03%)
PSXDIV20
83,897.76
44.40
(0.05%)
UPP9
64,179.51
-217.44
(-0.34%)
NITPGI
48,096.80
-234.92
(-0.49%)
NBPPGI
51,999.46
-268.92
(-0.51%)
MZNPI
31,606.87
-145.03
(-0.46%)
JSMFI
43,041.24
556.29
(1.31%)
ACI
24,135.20
1.54
(0.01%)
JSGBKTI
76,620.55
-623.35
(-0.81%)
HBLTTI
18,683.62
08-07-2026
5.21
(0.03%)
MII30
23,297.23
-72.51
(-0.31%)
Citi Pharma Ltd.
PHARMACEUTICALS
Rs.79.12
-0.26
(-0.33%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Thu, Jul 9, 2026 3:48 PM
REG
DFC
CSF
ODL
Open
78.90
High
81.00
Low
78.51
Volume
1,128,510
CIRCUIT BREAKER
71.44 — 87.32
DAY RANGE
78.51 — 81.00
52-WEEK RANGE ^
69.25 — 104.25
Ask Price
79.12
Ask Volume
0
Bid Price
79.12
Bid Volume
480
LDCP
79.38
VAR
12.50
HAIRCUT
17.50
P/E Ratio (TTM) **
16.45
1-Year Change * ^
-8.93%
YTD Change * ^
-6.48%
Last update: Thu, Jul 9, 2026 3:45 PM
Open
79.74
High
81.34
Low
79.41
Close
79.83
Change
-0.05%
LDCP
79.87
Volume
427,000
Total Trades
366
CIRCUIT BREAKER
71.88 — 87.86
DAY RANGE
79.41 — 81.34
Ask Price
79.83
Ask Volume
0
Bid Price
79.83
Bid Volume
0
Last update: Sun, May 31, 2026 3:02 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
81.15
Volume
0
Total Trades
0
CIRCUIT BREAKER
73.04 — 89.27
DAY RANGE
0.00 — 0.00
Ask Price
80.85
Ask Volume
0
Bid Price
80.85
Bid Volume
0
Last update: Sun, Apr 26, 2026 8:32 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
80.18
Volume
0
Total Trades
0
CIRCUIT BREAKER
72.16 — 88.20
DAY RANGE
0.00 — 0.00
Ask Price
79.88
Ask Volume
0
Bid Price
79.88
Bid Volume
0
Last update: Sun, Jun 28, 2026 3:32 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
82.12
Volume
0
Total Trades
0
CIRCUIT BREAKER
73.91 — 90.33
DAY RANGE
0.00 — 0.00
Ask Price
81.81
Ask Volume
0
Bid Price
81.81
Bid Volume
0

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

Citi Pharma Limited incorporated as a private limited company in Pakistan under the repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products.

KEY PEOPLE
Rizwan AhmadCEO
Nadeem AmjadChairperson
Muhammad Rasheed AlamCompany Secretary
ADDRESS

3-KM, Head Balloki Road, Bhai Pheru, Distt Kasur

WEBSITE

www.citipharma.com.pk

REGISTRAR

F.D Registrar Services (Pvt.) Ltd.

AUDITOR

Aslam Malik & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
18,075,850.14
Shares
228,461,200
Free Float
125,653,660
Free Float
55.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Apr 30, 2026Transmission of Quarterly Report for the Period Ended 31st March 2026 View   PDF
Apr 30, 2026Financial Results for the Quarter Ended 31 March 2026 View   PDF
Feb 18, 2026Transmission of Quarterly Financial Statements for the Period Ended 2025-12-31 View   PDF
Feb 13, 2026Financial Results for the Quarter Ended December 31, 2025 View   PDF
Oct 30, 2025TRANSMISSION OF QUARTERLY REPORT FOR THE PERIOD ENDED View   PDF
DateTitleDocument
Jul 9, 2026Certified Copy of the Resolutions Adopted in the Extraordinary General Meeting held on 08 July 2026 View   PDF
Jul 9, 2026Minutes of Extraordinary General Meeting
REVOKED
View   PDF
Jul 1, 2026Board Meeting Other Than Financial Results View   PDF
Jun 15, 2026Notice of Extraordinary General Meeting View   PDF
Apr 23, 2026Board Meeting View   
DateTitleDocument
Jul 8, 2026Material Information View   PDF
May 21, 2026Material Information View   PDF
May 6, 2026Material Information View   PDF
Apr 27, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Apr 23, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2025202420232022
Sales13,153,52112,409,23912,396,9839,779,880
Profit after Taxation892,039833,464657,984635,884
EPS3.903.652.882.88
Q3 2026Q2 2026Q1 2026Q3 2025
Sales3,084,7464,332,5663,370,2473,341,108
Profit after Taxation275,415404,334203,691220,375
EPS1.211.770.890.96
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2025202420232022
Gross Profit Margin (%)15.3412.7812.1613.83
Net Profit Margin (%)6.786.725.316.50
EPS Growth (%)6.8526.74(20.88)
PEG3.140.29(0.54)

Payouts

Financial Reports